galactosamine has been researched along with Chronic Lung Injury in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ates, B; Esrefoglu, M; Taslidere, E; Vardi, N; Yildiz, A | 1 |
| Bayrak, BB; Bolkent, S; Gezginci-Oktayoglu, S; Oztay, F; Yanardag, R | 1 |
1 review(s) available for galactosamine and Chronic Lung Injury
| Article | Year |
|---|---|
The effects of pentoxifylline and caffeic acid phenethyl ester on TNF-α and lung histopathology in D-galactosamine-induced pulmonary injury in rats.
Topics: Animals; Antioxidants; Caffeic Acids; Catalase; Galactosamine; Lung; Lung Injury; Malondialdehyde; Pentoxifylline; Rats; Superoxide Dismutase; Tumor Necrosis Factor-alpha | 2023 |
1 other study(ies) available for galactosamine and Chronic Lung Injury
| Article | Year |
|---|---|
Cathepsin B inhibition improves lung injury associated to D-galactosamine/tumor necrosis factor-alpha-induced liver injury in mice.
Topics: Animals; Apoptosis; Cathepsin B; Cell Proliferation; Chemical and Drug Induced Liver Injury; Cysteine Proteinase Inhibitors; Diazomethane; Galactosamine; Lung Injury; Male; Mice; Mice, Inbred BALB C; Tumor Necrosis Factor-alpha | 2010 |